Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates

Eitemau Tebyg

• Comparative In Vitro Activities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria
  gan: Citron, Diane M., et al.
  Cyhoeddwyd: (2012)
• Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence
  gan: Goldstein, Ellie J. C., et al.
  Cyhoeddwyd: (2014)
• In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
  gan: Citron, Diane M., et al.
  Cyhoeddwyd: (2012)
• In Vitro Activities of Dalbavancin and 12 Other Agents against 329 Aerobic and Anaerobic Gram-Positive Isolates Recovered from Diabetic Foot Infections
  gan: Goldstein, Ellie J. C., et al.
  Cyhoeddwyd: (2006)
• Comparative In Vitro Activities of GAR-936 against Aerobic and Anaerobic Animal and Human Bite Wound Pathogens
  gan: Goldstein, Ellie J. C., et al.
  Cyhoeddwyd: (2000)